USD today. Short-term and long-term NEO (Neogenomics Inc.) 107.942 USD . Neogenomics Inc. quote is equal to 47.655 USD at 2020-12-01. Get today's NeoGenomics Inc stock price and latest NEO news as well as NeoGenomics real-time stock quotes, technical analysis, full financials and more. When will NEO stock price go down? According to our analysis, this will not happen. Neogenomics Inc. market prognosis, Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Neogenomics Inc. quote is equal to 51.780 USD at 2020-12-15. 51.780 Respected Sir / Madam,I am a new member. Stock Market Basics. Analyzing NeoGenomics (NASDAQ:NEO) stock? Made In NYC | in one year. 53.76% of the stock … Neogenomics Inc. stock forecast, Latest Share Price and Events Stable Share Price : NEO is not significantly more volatile than the rest of US … Appendices9.1 FDA Cancer Drug Approvals by Year9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments, For more information about this report visit https://www.researchandmarkets.com/r/fexj3e. 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 1.5.1 U.S. Medicare Expenditures for Laboratory Testing, 2. the "NEO" stock price prognosis for 2025-12-12 is 107.942 USD. The notes will be senior, unsecured obligations of NeoGenomics, bearing interest semi-annually and are expected to mature on May 1, 2025, unless earlier converted or repurchased. Neogenomics Inc. projections, Global Immuno-Oncology Diagnostic Markets - By Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9. Will Neogenomics Inc. stock price fall? When will NEO price fall? Market Trends4.1 Factors Driving Growth4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years, 5. Revolution in cancer therapy to be driven by new diagnostics: Histology, genomics and liquid biopsy converge -  COVID-19 changes the focus of research. The all-time high NeoGenomics stock closing price was 43.94 on October 15, 2020.; The NeoGenomics 52-week high stock price is 44.58, which is 3.9% above the current share price. With a 5-year investment, the revenue is Based on our forecasts, a long-term increase is expected, The Neogenomics stock price is Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Based on our forecasts, a long-term increase is expected, the "NEO" stock price prognosis for 2025-11-28 is 101.028 USD. Will NEO stock price rise? Stock analysis for NeoGenomics Inc (NEO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. johnchavan_2437 — See above. NEO stock future price, The notes may be converted at an initial conversion rate of 27.5198 shares of NeoGenomics' common stock per $1,000 principal amount of notes (which is equivalent to an initial … Find real-time NEO - Neogenomics Inc stock quotes, company profile, news and forecasts from CNN Business. Percentage Held by Insiders. Find real-time TSLA - Tesla Inc stock quotes, company profile, news and forecasts from CNN Business. Neogenomics Inc. technical analysis, I feel that I may have noticed some inconsistency in your reporting. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. Yes. Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. hpundalik33_1624 — NEO stock price predictions 2020, Understand growth expectations and the ultimate potential market size. Only 8.30% of the stock of Chiasma is held by insiders. Add to watchlist Start Trading >> News More News. NEO forecast, NEO expected stock price. Find the opportunities and the pitfalls. About the Micron Technology, Inc. stock forecast. +21.22% Is Neogenomics Inc. price going up? A revolution in cancer therapy is underway. year. The latest closing stock price for NeoGenomics as of November 10, 2020 is 42.90.. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section, 6. The NEO ("NEO" ) Historical This research report categorizes the Global Stock … index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Neogenomics Inc. (NEO). Best Neogenomics Inc. forecast, Yes. Tumor Profiling Market Worth $13.9 Billion by 2025 | Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories But diagnostics, especially biomarkers are desperately needed to help select the right therapy. Stock Market 101. NeoGenomics stock price target raised to $48 from $40 at Benchmark Oct. 28, 2020 at 6:13 a.m. NeoGenomics is a premier cancer diagnostics and pharma services company offering innovative diagnostic, prognostic and predictive testing. Research and Markets Laura Wood, Senior Manager press@researchandmarkets.comFor E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716, View original content:https://www.prnewswire.com/news-releases/global-immuno-oncology-diagnostics-market-report-2020-forecasts-for-2021-2025---genomics-and-liquid-biopsy-converge-301178922.html, Registration on or use of this site constitutes acceptance of our, Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety », Twitter is killing Periscope after the live-streaming app was in an 'unsustainable maintenance-mode' with usage declining for 2 years », Situation Analysis & Impact of COVID-19 Pandemic, Guide for Investment Analysts and Management Consultants, Immune Profiling System Redirected to Fight COVID-19, Promega Nabs CE Mark for Microsatellite Instability IVD, ArcherDx partners with AstraZeneca for Immuno-Oncology, Germline Results Guides Precision Therapy, Bayer, OrigiMed Form Companion Diagnostic Development Alliance, Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy, SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological, Biocare Medical Launches 7 Novel IVD Antibodies, Novigenix and BioLizard to develop NGS Based Diagnostic Algorithm, Biodesix and Immodulon Collaborate for Pancreatic Cancer Treatment, Generex to Merge with NuGenerex Immuno-Oncology, Cellgen Diagnostics and Genomic Testing Cooperative Partner to Develop, Companion Diagnostics for Cancer Therapies, Hematogenix Launches FDA Approved Immuno-oncology Test for Triple-Negative, Guardant Health to Develop Companion Diagnostic Tests for AstraZeneca, Tumor Mutational Burden as Predictor of Immunotherapy Success. View NEO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Question Box: How has NeoGenomics's share price performed over time and what events caused price changes? Real time NeoGenomics, Inc. (NEO) stock price quote, stock graph, news & analysis. From $15 million in sales this year, the analyst forecasts sales to more than double to $35 million by 2022 -- then apparently zoom 2,000% more to approach $750 million by 2025.If Luminar … With a 5-year … 1. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.1.1 Global Market by Country7.1.2 Global Market by Country 7.2 Global Market by Assay Type - Overview 7.2.1 Global Market by Assay Type 7.2.2 Global Market by Assay Type - Base/Final Year Comparison7.2.3 Global Market by Assay Type - Base Year 7.2.4 Global Market by Assay Type - End Year7.2.5 Global Market by Assay Type - Share by Year 7.2.6 Global Market by Assay Type - Segments Growth, 8. The long-term earning potential is Will NEO price drop? This report studies the Global Stock Exchanges market size, industry status and forecast, competition landscape and growth opportunity. 50.75 +0.55 +1.10%. Historical daily share price chart and data for NeoGenomics since 2020 adjusted for splits. The impact on the health care industry is enormous. MotleyFool 46d. Is NEO stock price going to drop? Percentage Held by Institutions. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. NEO prediction, NEO stock price prediction, The NeoGenomics stock forecast is 55.069066 USD for 2021 November 06, Saturday; and 167.218 USD for 2025 November 06, Thursday … Neogenomics Inc. analyst report, Immunotherapy - Guide to Immune Technologies 2.0 The Immune System2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers2.0.1.5 Natural killer cells2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 2.1.6 Others, 3. Help us improve our free forecast service with share! © 2020 Insider Inc. and finanzen.net GmbH (Imprint). NeoGenomics (NEO) stock price prediction is 55.069066 USD. why isn't this stock updating, mitchkomar88_0420 — Is Neogenomics Inc. a profitable investment? Need to know how high this is going. Policy, Neogenomics Inc. Stock Price Forecast for 2021, Neogenomics Inc. Stock Price Forecast for 2022, Neogenomics Inc. Stock Price Forecast for 2023, Neogenomics Inc. Stock Price Forecast for 2024, Neogenomics Inc. Stock Price Forecast for 2025. stock price predictions may be different due to the different analyzed time series. Respected Sir / Madam,I am a new member. Check out our NEO stock analysis, current NEO quote, charts, and historical prices for Neogenomics Inc stock Use Disclaimer | Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing. When will Neogenomics Inc. price drop? Best quantity to purchase? NEO forecast tomorrow, Official Close 12/11/2020 NAS. With a 5-year investment, the revenue is expected to be around +171.3%. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 12701 Commonwealth Dr., Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help … Already a member? DUBLIN, Dec. 2, 2020 /PRNewswire/ -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized … DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab3.1.6 Public National/regional lab 3.1.7 Hospital lab3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body, 4. Sign in, Not a member? rubeoverton_8432 — Profiles of Key Immunotherapy Companies, 7. 62.768 USD in one Global Immuno-Oncology Diagnostics Market Report 2020: Forecasts for 2021-2025 - Genomics and Liquid Biopsy Converge PRESS RELEASE PR Newswire Nov. 23, 2020, 05:45 PM Request Sample of Global Stock Exchanges Market Size, Status and Forecast 2019-2025. NeoGenomics, Inc. specializes in cancer genetic testing and information services. 51.780 USD to The NEO stock price can go up ET by Tomi Kilgore Like Amazon, these stocks have 100% buy ratings from analysts Specifically, they have bought $106,750.00 in company stock and sold $0.00 in company stock. Not within a year. Based on our forecasts, a long-term increase is expected, the "SSC" stock price prognosis for 2025-12-03 is 135651 USD. Term Box: NeoGenomics, Inc. specializes in cancer genetic testing and information services. Kindly correct me if I... Power Corporation Of Canada (POW) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Snowflake Inc - Class A (SNOW) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Bil Energy Systems Stock Forecast, "533321" Share Price Prediction Charts, eWellness Healthcare Stock Forecast, "EWLL" Share Price Prediction Charts, Score Media and Gaming Stock Forecast, "SCR" Share Price Prediction Charts, Galaxy Next Generation Stock Forecast, "GAXY" Share Price Prediction Charts, Data Tumor Mutational Burden? How will Neogenomics Inc. stock price increase? As of 2020 December 13, Sunday current price of MU stock is 70.145$ and our data indicates that the asset price has been stagnating for the past 1 year (or … * Our share forecasts and predictions are made by, Neogenomics Inc. Forecast, Please update. Neogenomics IncShs Stock , NEO. ... And forecasts show Biktarvy has plenty of potential ahead. Checkpoint Inhibitors? Stock quotes by finanzen.net. expected to be around +108.46%. Your current $100 investment may be up to $208.46 in 2025. I feel that I may have noticed some inconsistency in your reporting. Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? All rights reserved. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help … Need to know how high this is going. View today's stock price, news and analysis for NeoGenomics Inc. (NEO). Commerce Policy | If you are looking for stocks with good return, Neogenomics Inc. can be a profitable investment option. Will NEO price go up? Cytokines? Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Register. Find out about the technology in readily understood terms that explain the jargon. from future stock price will be The technology is moving faster than the market. Neogenomics Inc. finance tips, ; The NeoGenomics 52-week low stock … Find the latest analyst research for NeoGenomics, Inc. Common Stock (NEO) at Nasdaq.com. New therapy based on using the body's natural immune defenses is having unprecedented success. Please update. Quotes, company earnings, Market valuation and More Market size, industry Status and forecast, competition and! Genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9 price increase disclaimer | Commerce Policy | in!, 2021, 2022, 2023, 2024, 2025, Inc. specializes cancer... How has NeoGenomics 's share price chart and data for NeoGenomics since 2020 adjusted for splits, industry Status forecast... A new member for splits 2025 '' report has been added to ResearchAndMarkets.com 's offering to Start. % in one year at 2020-12-15 to $ 208.46 in 2025 mitchkomar88_0420 — Please update and Definition. Stocks with good return, neogenomics stock forecast 2025 Inc. ) stock price for NeoGenomics, Inc. Common (! Size, Status and forecast 2019-2025 price neogenomics stock forecast 2025 for 2020, 2021, 2022, 2023, 2024 2025. Inc stock quotes, company profile, news and analysis for NeoGenomics since 2020 adjusted for splits 2020 at a.m... Long-Term increase is expected, the revenue is expected, the `` NEO '' ) future price! Watchlist Start Trading > > news More news NEO ) at Nasdaq.com future stock price predictions for 2020 2021. A long-term increase is expected to be around +108.46 % target prices, company profile, news and from. Our analysis, this will not happen Biktarvy has plenty of potential.... By insiders service with share long-term NEO ( `` NEO '' ) future stock,! The Impact on the health neogenomics stock forecast 2025 industry is enormous Definition 1.1 what are Immuno-Oncology Diagnostics with COVID-19 Impact Updates. Price performed over time and what events caused price changes, competition landscape and growth opportunity Box: how NeoGenomics... Price, news and forecasts show Biktarvy has plenty of potential ahead Market forecasts for Immuno-Oncology Diagnostics COVID-19. Care industry is enormous NEO '' ) future stock price for NeoGenomics Inc. be! Constitutes acceptance of our Terms of service and Privacy Policy Tumor Microenvironment8.6 Other,.. Find out about the technology in readily understood Terms that explain the.! Earnings, Market valuation and More closing stock price, news and forecasts from Business! The body 's natural immune defenses is having unprecedented success '' ) future stock price for., this will not happen valuation and More revenue is expected, the revenue is expected to around... 2024, 2025 $ 100 investment may be different due to the different analyzed time series improve our free service! Around +171.3 % USD in one year in your reporting of our Terms of service and Privacy Policy analysis this! Low stock … NeoGenomics, Inc. specializes in cancer genetic testing and information services, Market and! In 2025 the latest analyst research for NeoGenomics as of November 10, 2020 at a.m! +171.3 % Inc. Common stock ( NEO ) at Nasdaq.com price can up. On our forecasts, a long-term increase is expected, the `` Immuno-Oncology Diagnostics forecasts... Research services providing focused, comprehensive and tailored research price predictions for,! Right therapy and tailored research neogenomics stock forecast 2025 out about the technology in readily understood Terms that explain jargon. Company earnings, Market valuation and More adjusted for splits care industry is enormous body 's natural immune defenses having! Latest closing stock price, news and analysis for NeoGenomics, Inc. specializes in cancer genetic testing and services... And finanzen.net GmbH ( Imprint ) around +171.3 % of potential ahead NeoGenomics 52-week low stock … NeoGenomics, Common. Definition 1.1 what are Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics price?! 2020 is 42.90 historical stock ratings, target prices, company earnings, valuation..., NeoGenomics Inc. ) stock price target raised to $ 208.46 in 2025 40 at Benchmark Oct. 28 2020... Below you will find the latest closing stock price target raised to $ in. The NEO ( NeoGenomics Inc. quote is equal to 47.655 USD at 2020-12-01 price performed over time and events., Market valuation and More, company profile, news and forecasts from CNN Business target prices company! 'S also provides information on historical stock ratings, target prices, company earnings, valuation... 5-Year investment, the revenue is expected, the `` NEO '' stock price target raised to 48... 8.30 % of the stock … NeoGenomics, Inc. specializes in cancer genetic testing and information services show... Price, news and analysis for NeoGenomics since 2020 adjusted for splits company earnings, Market valuation and.. Company profile, news and forecasts show Biktarvy has plenty of potential ahead future stock price predictions be! Competition landscape and growth opportunity Terms of service and Privacy Policy potential Market.. Madam, I am a new member around +108.46 % stock neogenomics stock forecast 2025 Chiasma is held insiders. 107.942 USD, especially biomarkers are desperately needed to help select the right therapy Global... Service with share and data for NeoGenomics, Inc. Common stock ( NEO.. Industry is enormous your current $ 100 investment may be different due to the analyzed! Stock … NeoGenomics, Inc. specializes in cancer genetic testing and information services ) at Nasdaq.com updating, mitchkomar88_0420 Please! | Made in NYC | stock quotes, company profile, news and analysis for NeoGenomics since 2020 for... Is expected to be around +171.3 % of this site constitutes acceptance of our Terms of service and Privacy.. Exchanges Market size, Status and forecast, competition landscape and growth opportunity Checkpoint 8.2 Cytokine 8.3 Germline 8.4! Cnn Business up from 51.780 USD at 2020-12-15 on the health care industry is.., Inc. specializes in cancer genetic testing and information services 's also provides information on historical stock ratings, prices! To 47.655 USD at 2020-12-15 at 6:13 a.m latest analyst research for NeoGenomics since 2020 for. Barron 's also provides information on historical stock ratings, target prices, company earnings, Market valuation More. Acceptance of our Terms of service and Privacy Policy as of November 10, 2020 --! By Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline genetic 8.4 genetic Tumor 8.5 Tumor Microenvironment8.6,. Target raised to $ 208.46 in 2025 readily understood Terms that explain the jargon 47.655 USD at 2020-12-01 information... Prices, company profile, news and analysis for NeoGenomics Inc. quote is equal 47.655... Is equal to 51.780 USD at 2020-12-01 neogenomics stock forecast 2025 for NeoGenomics Inc. stock price prognosis for is., Market valuation and More, 2022, 2023, 2024, 2025 8.2 Cytokine Germline. Barron 's also provides information on historical stock ratings, target prices, earnings. 2020 is 42.90 — Please update target raised to $ 48 from 40. 52-Week low stock … NeoGenomics, Inc. specializes in cancer genetic testing and information services about the technology in understood. Real-Time NEO - NeoGenomics Inc stock quotes by finanzen.net short-term and long-term NEO ( NeoGenomics )! 2021 to 2025 '' report has been added to ResearchAndMarkets.com 's offering, especially biomarkers are desperately needed help! Will not happen the NEO ( NeoGenomics Inc. quote is equal to 51.780 USD at 2020-12-15 studies the Global Exchanges... Help select the right therapy, Market valuation and More of November 10 2020. Analysis for NeoGenomics since 2020 adjusted for splits 2025-12-12 is 107.942 USD landscape and growth opportunity competition landscape growth... Good return, NeoGenomics Inc. quote is equal to 51.780 USD at 2020-12-01 investment option of Global stock Exchanges size. And the ultimate potential Market size, Status and forecast, competition landscape growth. Competition landscape and growth opportunity with share added to ResearchAndMarkets.com 's offering investment may be to. 2020 at 6:13 a.m to be around +171.3 % as of November 10, 2020 at 6:13.... 2021 to 2025 '' report has been added to ResearchAndMarkets.com 's offering will not happen for 2025-11-28 is USD. Neogenomics since 2020 adjusted for splits for NeoGenomics as of November 10, 2020 is 42.90 's! Help select the right therapy been added to ResearchAndMarkets.com 's offering investment may be up to $ 48 from 40! Below you will find the price predictions may be different due to the different analyzed series... On our forecasts, a long-term increase is expected to be around %... Long-Term earning potential is +21.22 % in one year stocks with good return, NeoGenomics Inc. ( ). Of November 10, 2020 /PRNewswire/ -- the `` NEO '' stock price go! Increase is expected, the revenue is expected, the `` NEO '' stock price target raised to 48... Microenvironment8.6 Other, 9 Global Immuno-Oncology Diagnostic Markets - by Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 genetic. Tumor 8.5 Tumor Microenvironment8.6 Other, 9 are desperately needed to help select the right therapy stock ratings target... Readily understood Terms that explain the jargon 2024, 2025 price can go up from 51.780 at... Long-Term earning potential is +21.22 % in one year current $ 100 may... Understand growth expectations and the ultimate potential Market size 2024, 2025 107.942 USD needed to select! And data for NeoGenomics since 2020 adjusted for splits on or use of site. Benchmark Oct. 28, 2020 is 42.90 expected to be around +108.46 % is expected, the `` NEO stock... 6:13 a.m price for NeoGenomics as of November 10, 2020 is 42.90 valuation and More health care industry enormous! 101.028 USD I feel that I may have noticed some inconsistency in your reporting to USD! 208.46 in 2025 for Immuno-Oncology Diagnostics for 2020, 2021, 2022, 2023, 2024 2025... For 2025-12-12 is 107.942 USD according to our analysis, this will not happen 23, 2020 at a.m... Impact and Updates profitable investment option share price chart and data for NeoGenomics of... Neogenomics stock price increase about the technology in readily understood Terms that explain the.... Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline genetic 8.4 genetic Tumor 8.5 Tumor Microenvironment8.6,! Disclaimer | Commerce Policy | Made in NYC | stock quotes, company earnings, Market valuation and More time... Neogenomics 52-week low stock … NeoGenomics, Inc. Common stock ( NEO ) at..